These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 9562649)

  • 1. Hemodynamic performances in patients treated with sotalol after electrical cardioversion of atrial fibrillation.
    Dan GA; Gonţa A
    Rom J Intern Med; 1997; 35(1-4):19-27. PubMed ID: 9562649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aggravation of postcardioversion atrial dysfunction by sotalol.
    Pollak A; Falk RH
    J Am Coll Cardiol; 1995 Mar; 25(3):665-71. PubMed ID: 7860911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of oral magnesium, alone or as an adjuvant to sotalol, after cardioversion in patients with persistent atrial fibrillation.
    Frick M; Darpö B; Ostergren J; Rosenqvist M
    Eur Heart J; 2000 Jul; 21(14):1177-85. PubMed ID: 10924301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maintenance of sinus rhythm after electrical cardioversion of persistent atrial fibrillation; sotalol vs bisoprolol.
    Plewan A; Lehmann G; Ndrepepa G; Schreieck J; Alt EU; Schömig A; Schmitt C
    Eur Heart J; 2001 Aug; 22(16):1504-10. PubMed ID: 11482924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Left atrial and appendage mechanical function after pharmacological or electrical cardioversion in patients with chronic atrial fibrillation: a multicenter, randomized study.
    Mazzone C; Pandullo C; Scardi S; Salvi R; Miccio M; Cattarini G; Morgera T
    Ital Heart J; 2000 Feb; 1(2):128-36. PubMed ID: 10730613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement in exercise performance after successful cardioversion in patients with persistent atrial fibrillation and symptoms of heart failure.
    Wozakowska-Kapłon B; Opolski G
    Kardiol Pol; 2003 Sep; 59(9):213-23. PubMed ID: 14618198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized trial of prophylactic antiarrhythmic agents (amiodarone and sotalol) in patients with atrial fibrillation for whom direct current cardioversion is planned.
    Vijayalakshmi K; Whittaker VJ; Sutton A; Campbell P; Wright RA; Hall JA; Harcombe AA; Linker NJ; Stewart MJ; Davies A; de Belder MA
    Am Heart J; 2006 Apr; 151(4):863.e1-6. PubMed ID: 16569550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Idiopathic atrial fibrillation of recent onset and atrial stunning: the echocardiographic evidence after pharmacological cardioversion].
    Ciolli A; De Sisti A; Montenero AS; Sanna T; Lo Sardo G; Palamara A
    Cardiologia; 1998 Oct; 43(10):1077-82. PubMed ID: 9922572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rate control vs rhythm control in patients with nonvalvular persistent atrial fibrillation: the results of the Polish How to Treat Chronic Atrial Fibrillation (HOT CAFE) Study.
    Opolski G; Torbicki A; Kosior DA; Szulc M; Wozakowska-Kaplon B; Kolodziej P; Achremczyk P;
    Chest; 2004 Aug; 126(2):476-86. PubMed ID: 15302734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic electrocardioversion for atrial fibrillation and role of antiarrhythmic drugs: a substudy of the SAFE-T trial.
    Singh SN; Tang XC; Reda D; Singh BN
    Heart Rhythm; 2009 Feb; 6(2):152-5. PubMed ID: 19187902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of amiodarone versus sotalol in treatment of atrial fibrillation: a random controlled clinical study].
    Niu F; Huang CX; Jiang H; Yang B; Guo WL; Chen YX; Jin CR; Liu ZM
    Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(2):121-3. PubMed ID: 16620720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exercise capacity in atrial fibrillation: a substudy of the Sotalol-Amiodarone Atrial Fibrillation Efficacy Trial (SAFE-T).
    Atwood JE; Myers JN; Tang XC; Reda DJ; Singh SN; Singh BN
    Am Heart J; 2007 Apr; 153(4):566-72. PubMed ID: 17383295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ibutilide in persistent atrial fibrillation refractory to conventional cardioversion methods.
    Naegeli B; Straumann E; Bertel O
    Int J Cardiol; 2005 Mar; 99(2):283-7. PubMed ID: 15749188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effectiveness and safety of d,l-sotalol in the ambulatory treatment of atrial fibrillation and flutter].
    Cruz Cruz F; Iturralde Torres P; Picos Bovio E; Medeiros Domingo A; Infante Vázquez O
    Arch Inst Cardiol Mex; 1998; 68(6):482-91. PubMed ID: 10365224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of sinus rhythm restoration in patients with persistent atrial fibrillation: a clinical, echocardiographic and hormonal study.
    Wozakowska-Kapłon B; Opolski G
    Int J Cardiol; 2004 Aug; 96(2):171-6. PubMed ID: 15262030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of sotalol on heart rate, QT interval, and atrial fibrillation cycle length in horses with atrial fibrillation.
    Decloedt A; Broux B; De Clercq D; Deprez P; Van Steenkiste G; Vera L; Ven S; van Loon G
    J Vet Intern Med; 2018 Mar; 32(2):815-821. PubMed ID: 29460446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atrial fibrillation: rate control often better than rhythm control.
    Prescrire Int; 2004 Apr; 13(70):64-9. PubMed ID: 15148984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and proarrhythmic hazards of pharmacologic cardioversion of atrial fibrillation: prospective comparison of sotalol versus quinidine.
    Hohnloser SH; van de Loo A; Baedeker F
    J Am Coll Cardiol; 1995 Oct; 26(4):852-8. PubMed ID: 7560608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction over time of QTc prolongation in patients with sotalol after cardioversion of atrial fibrillation.
    Lenhoff H; Darpö B; Ferber G; Rosenqvist M; Frick M
    Heart Rhythm; 2016 Mar; 13(3):661-8. PubMed ID: 26654918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of prevention of heart failure by serial electrical cardioversion in patients with persistent atrial fibrillation.
    Tuinenburg AE; Van Gelder IC; Van Den Berg MP; Brügemann J; De Kam PJ; Crijns HJ
    Heart; 1999 Oct; 82(4):486-93. PubMed ID: 10490566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.